| Signature Healthcare Of Palm Beach | |
| 4405 Lakewood Road, Lake Worth, Florida 33461 | |
| (561) 969-1400 | |
| Name | Signature Healthcare Of Palm Beach |
|---|---|
| Location | 4405 Lakewood Road, Lake Worth, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 62% |
| Medicare ID (CCN) | 105466 |
| Legal Business Name | Lp Lake Worth Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1477744746 |
| Organization Name | LP LAKE WORTH LLC |
| Doing Business As | SIGNATURE HEALTHCARE OF PALM BEACH |
| Address | 4405 Lakewood Rd, Lake Worth, FL 33461 |
| Phone Number | 561-969-1400 |
News Archive
Scientists at The Scripps Research Institute have developed a broadly useful method to unmask new functional features of human proteins.
Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.
Nurse Leslie McKamey has gotten used to the 16-hour shifts, to skipping lunch, to the nightly ritual of throwing all her clothes in the laundry and showering as soon as she walks through the door to avoid potentially infecting her children.
Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.
› Verified 5 days ago
| NPI Number | 1659350114 |
| Organization Name | HQM OF SUTTON PLACE, LLC |
| Doing Business As | SUTTON PLACE CARE CENTER |
| Address | 4405 Lakewood Rd, Lake Worth, FL 33461 |
| Phone Number | 561-969-1400 |
News Archive
Scientists at The Scripps Research Institute have developed a broadly useful method to unmask new functional features of human proteins.
Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.
Nurse Leslie McKamey has gotten used to the 16-hour shifts, to skipping lunch, to the nightly ritual of throwing all her clothes in the laundry and showering as soon as she walks through the door to avoid potentially infecting her children.
Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.
› Verified 5 days ago
| NPI Number | 1932835295 |
| Organization Name | PALM BEACH NURSING CENTER LLC |
| Address | 4405 Lakewood Rd, Lake Worth, FL 33461 |
| Phone Number | 561-969-1400 |
News Archive
Scientists at The Scripps Research Institute have developed a broadly useful method to unmask new functional features of human proteins.
Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.
Nurse Leslie McKamey has gotten used to the 16-hour shifts, to skipping lunch, to the nightly ritual of throwing all her clothes in the laundry and showering as soon as she walks through the door to avoid potentially infecting her children.
Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Scientists at The Scripps Research Institute have developed a broadly useful method to unmask new functional features of human proteins.
Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.
Nurse Leslie McKamey has gotten used to the 16-hour shifts, to skipping lunch, to the nightly ritual of throwing all her clothes in the laundry and showering as soon as she walks through the door to avoid potentially infecting her children.
Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $23979 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.3 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0.6 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 78.79 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.54 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.79 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.53 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 1.03 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.29 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.17 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 16.93 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 34.52 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.91 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 80.45 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.9 | 82.93 |
News Archive
Scientists at The Scripps Research Institute have developed a broadly useful method to unmask new functional features of human proteins.
Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.
Nurse Leslie McKamey has gotten used to the 16-hour shifts, to skipping lunch, to the nightly ritual of throwing all her clothes in the laundry and showering as soon as she walks through the door to avoid potentially infecting her children.
Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.
› Verified 5 days ago
Terraces Of Lake Worth Care Center Location: 1711 6th Avenue South, Lake Worth, Florida 33460 Phone: (561) 586-0808 | |
Medicana Nursing And Rehab Center Location: 1710 Lake Worth Road, Lake Worth, Florida 33460 Phone: (561) 582-5331 | |
Signature Healthcare Of Palm Beach Location: 4405 Lakewood Road, Lake Worth, Florida 33461 Phone: (561) 969-1400 | |
Oasis Health And Rehabilitation Center Location: 1201 12th Avenue South, Lake Worth, Florida 33460 Phone: (561) 586-7404 | |